2-(1-氰基-1-乙基丙基)苯甲腈 | 1027535-06-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(1-氰基-1-乙基丙基)苯甲腈
• 英文名称: 2-(1-cyano-1-ethylpropyl)benzonitrile
• 英文别名: 2-(3-Cyanopentan-3-yl)benzonitrile
• CAS: 1027535-06-3
• 化学式: C₁₃H₁₄N₂
• 分子量: 198.268
• InChiKey: HAOVDBMXXPXAIP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  47.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(1-氰基-1-乙基丙基)苯甲腈 在 platinum(IV) oxide 硫酸 、 氢气 、 硝酸 作用下， 以 甲醇 为溶剂， -20.0~65.0 ℃ 、344.75 kPa 条件下， 生成 7,8-Diamino-4,4-diethylisoquinoline-1,3-dione
  参考文献：
  名称：

  Discovery of 2-Phenylamino-imidazo[4,5-h]isoquinolin-9-ones:  A New Class of Inhibitors of Lck Kinase

  摘要：

  An imidazo[4,5-h]isoquinolin-7,9-dione (1) was identified as an adenosine 5'-triphosphate competitive inhibitor of lck by high throughput screening. Initial structure-activity relationship studies identified the dichlorophenyl ring and the imide NH as important pharmacophores. A binding model was constructed to understand how 1 binds to a related kinase, lick. These results suggested that removing the gem-dimethyl group and flattening the ring would enhance activity. This was realized by converting 1 to the imidazo[4,5-h]isoquinolin-9-one (20), resulting in an 18-fold improvement in potency against lck and a 50-fold increase in potency in a cellular assay.

  DOI：

  10.1021/jm020113o
• 作为产物：
  描述：

  alpha-氰基-邻-苯乙腈 、 碘乙烷 在 四丁基溴化铵 、 sodium hydroxide 作用下， 以 水 为溶剂， 反应 48.0h， 以69%的产率得到2-(1-氰基-1-乙基丙基)苯甲腈
  参考文献：
  名称：

  1,3,5-三氮杂戊二烯通过1,3-和1,4-二腈的亲核加成-通过结合到循环外围中的空间受限实例：合成，聚集和光物理性质

  摘要：

  由于主要的n /π*相互作用，1,3,5-三氮杂戊二烯通常在N–C–N–C–N骨架上呈U形或扭曲的S形构象。但是，如果1,3,5-三氮杂戊二烯单元是环的一部分，则其W构象可能仅限于平面。在这里，我们描述了13个新的1,3,5- triazapentadienes合成10 - 12，它们在空间上通过掺入抑制成六元或七元环系统，通过加入锂化的伯胺或肼的5到二腈7，8或9两个氰基的距离为1,3或1,4。这些新型化合物由于氢键而显示出非常强的聚集趋势，尤其是从固态X射线数据可以看出，它们形成同二聚体。额外的氢键还在晶体中产生线性链。几种新化合物在溶液中显示荧光。量子化学DFT计算用于评估二聚能和光物理性质的解释。

  DOI：

  10.1021/acs.joc.6b00126

文献信息

• 1,3,5-Triazapentadienes by Nucleophilic Addition to 1,3- and 1,4-Dinitriles—Sterically Constrained Examples by Incorporation into Cyclic Peripheries: Synthesis, Aggregation, and Photophysical Properties
  作者：Agnes Johanna Wrobel、Ralph Lucchesi、Birgit Wibbeling、Constantin-Gabriel Daniliuc、Roland Fröhlich、Ernst-Ulrich Würthwein

  DOI：10.1021/acs.joc.6b00126

  日期：2016.4.1

  with the two cyano groups in 1,3 or 1,4 distance. These novel compounds show very strong tendency for aggregation due to hydrogen bonding, especially to form homodimers as seen from X-ray data in the solid state. Additional hydrogen bonding generates also linear chains in the crystal. Several of the new compounds show fluorescence in solution. Quantum chemical DFT calculations were used for evaluation

  由于主要的n /π*相互作用，1,3,5-三氮杂戊二烯通常在N–C–N–C–N骨架上呈U形或扭曲的S形构象。但是，如果1,3,5-三氮杂戊二烯单元是环的一部分，则其W构象可能仅限于平面。在这里，我们描述了13个新的1,3,5- triazapentadienes合成10 - 12，它们在空间上通过掺入抑制成六元或七元环系统，通过加入锂化的伯胺或肼的5到二腈7，8或9两个氰基的距离为1,3或1,4。这些新型化合物由于氢键而显示出非常强的聚集趋势，尤其是从固态X射线数据可以看出，它们形成同二聚体。额外的氢键还在晶体中产生线性链。几种新化合物在溶液中显示荧光。量子化学DFT计算用于评估二聚能和光物理性质的解释。
• Discovery of 2-Phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones:  A New Class of Inhibitors of Lck Kinase
  作者：Roger J. Snow、Mario G. Cardozo、Tina M. Morwick、Carl A. Busacca、Yong Dong、Robert J. Eckner、Stephen Jacober、Scott Jakes、Suresh Kapadia、Susan Lukas、Maret Panzenbeck、Gregory W. Peet、Jeffrey D. Peterson、Anthony S. Prokopowicz、Rosemarie Sellati、Robert M. Tolbert、Matt A. Tschantz、Neil Moss

  DOI：10.1021/jm020113o

  日期：2002.8.1

  An imidazo[4,5-h]isoquinolin-7,9-dione (1) was identified as an adenosine 5'-triphosphate competitive inhibitor of lck by high throughput screening. Initial structure-activity relationship studies identified the dichlorophenyl ring and the imide NH as important pharmacophores. A binding model was constructed to understand how 1 binds to a related kinase, lick. These results suggested that removing the gem-dimethyl group and flattening the ring would enhance activity. This was realized by converting 1 to the imidazo[4,5-h]isoquinolin-9-one (20), resulting in an 18-fold improvement in potency against lck and a 50-fold increase in potency in a cellular assay.